Novo Nordisk filed a patent term extension (PTE) application with Chinas CNIPA in 2024, which was rejected on September 25, 2025
Extensive research continues to underscore the efficacy of semaglutide injections in facilitating weight loss, emphasizing the shift towards treating obesity as a chronic metabolic condition rather than solely relying on lifestyle modifications
These insights can support a more informed conversation with your healthcare provider about your individual metabolic profile and whether GLP-1 therapy aligns with your genetic and physiologic landscape
The term "antioxidant" refers to a substance that helps neutralize free radicals
Wegovy pill is not currently available to request on the NHS
Expression levels were reported as raw read counts, TPM (transcripts per million), and FPKM (fragments per kilobase of transcript per million mapped reads), as applicable